InvestorsHub Logo

bradfordbros

06/21/21 1:15 PM

#363149 RE: bradfordbros #363148

In my mind’s eye there is a very big footprint for Brilacidin which, if perceived by new investors, will lead to an increasing share price and a new image for Ipix.

wsbc

06/21/21 1:19 PM

#363151 RE: bradfordbros #363148

...Sure... How many grants have we rec'd to-date?

How many completed P2's do we have and for how many different indications?

How many signed deals does the company have for these and what's our revenue stream look like after 15yrs of this?

How many PR's about 'negotiating with/presenting at/in-conversation with' have we seen over the years? Who's netted compensation for these 'negotiations/presentations/etc'?

Notice a pattern here yet?


Doesn’t new data on non-sars-cov-2 endemic viral diseases potentially increase the scope for Brilacidin. The news is coming and it WILL be picked up by the scientific press which can only be good for Ipix. Grants coming our way soon?